Status:
COMPLETED
A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES)
Lead Sponsor:
Genentech, Inc.
Conditions:
Colorectal Cancer
Non-Small Cell Lung Cancer
Eligibility:
All Genders
Brief Summary
This is an observational study designed to follow patients with metastatic or locally advanced and unresectable CRC or locally advanced or metastatic NSCLC (excluding predominant squamous histology) w...
Eligibility Criteria
Inclusion
- Signed Informed Consent Form
- Metastatic or locally advanced and unresectable CRC or locally advanced or metastatic NSCLC (excluding predominant squamous histology)
- Eligible for Avastin as a component of intended therapy
- First-line chemotherapy (or second-line chemotherapy for CRC) plus Avastin initiated ≤ 4 months prior to study enrollment
Exclusion
- Any medical condition, including mental illness or substance abuse, deemed by the investigator to be likely to interfere with a patient's ability to provide informed consent or comply with the treatment and follow-up, as specified by the investigator
- Enrollment in a blinded, placebo-controlled bevacizumab trial
Key Trial Info
Start Date :
November 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
3998 Patients enrolled
Trial Details
Trial ID
NCT00388206
Start Date
November 1 2006
End Date
March 1 2012
Last Update
December 12 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.